Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Transcat acquires Southeastern Biomedical for expansion

PUBLIC · TRNSAug 31, 2026•7 days ago

Acquiring Company

Transcat

Acquired Company

Southeastern Biomedical

RochesterManufacturingBiotechnologyBiotechnologyHealth CareMedical Device

Description

Transcat has expanded its biomedical calibration channel by acquiring Southeastern Biomedical. This acquisition enhances Transcat's capabilities in the biomedical sector. The move is aimed at delivering improved services to healthcare facilities. Further details on the transaction terms were not disclosed.

Company Information

Company

Transcat

Location

Rochester, New York, United States

About

Transcat, Inc. is a leading provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, computerized maintenance management system, and pipette services. The Company is focused on providing best-in-class services and products to highly regulated industries, particularly the Life Science industry, which includes pharmaceutical, biotechnology, medical device, and other FDA-regulated businesses, as well as aerospace and defense, and energy and utilities. Transcat provides periodic on-site services, mobile calibration services, pickup and delivery, in-house services at its 27 Calibration Service Centers strategically located across the United States, Puerto Rico, Canada, and Ireland. In addition, Transcat operates calibration labs in 21 imbedded customer-site locations. The breadth and depth of measurement parameters addressed by Transcat’s ISO/IEC 17025 scopes of accreditation are believed to be the best in the industry.

Don't miss Transcat's next move

Get an email the moment Transcat makes an acquisition, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Steve
Likely contact at this company
••••••••@••••••••

See Steve's verified email →

John
Likely contact at this company
••••••••@••••••••

See John's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for Transcat's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired Southeastern Biomedical?

Southeastern Biomedical was acquired by Transcat, based in Rochester. The deal was reported on August 31, 2026. Transcat, Inc. is a leading provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, computerized maintenance management system, and pipette services. Transcat is publicly traded (TRNS) and operates in Manufacturing.

When did Transcat acquire Southeastern Biomedical?

Transcat's acquisition of Southeastern Biomedical was reported on August 31, 2026. Transcat has expanded its biomedical calibration channel by acquiring Southeastern Biomedical. This acquisition enhances Transcat's capabilities in the biomedical sector. The move is aimed at delivering improved services to healthcare facilities. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Southeastern Biomedical do?

Southeastern Biomedical is a company focused on biomedical equipment calibration and support. It provides services for healthcare facilities to ensure compliance and operational efficiency. It is privately held, operating in Biotechnology.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.